A d e c r e a s e i n high d e n s i t y l i p o p r o t e i n c h o l e s t e r o l (HDL,), one of the major risk f a c t o r s f o r coronary a r t e r y d i s e a s e , o c c u r s during puberty i n males. Previous s t u d i e s have shown t h i s e f f e c t w i t h T therapy f o r a d o l e s c e n t males a t puberty (Kirkland, RT, e t a1 ;JAMA, i n p r e s s ) . The mechanism o f a c t i o n i s unknown. Normal ranges for T, DHT, HDLc f o r t h i s s p e c i e s were e s t a b l i s h e d . A f t e r Cx, androgens decreased and HDLc increased s i g n i f i c a n t l y . Therapy w i t h T and a nonaromatizeable androgen(DHT) a f t e r Cx both produced a s i g n i f i c a n t d e c r e a s e i n HDLc. Simultaneous therapy with T and 4-MA d i d n o t i n c r e a s e HDL from Cx+ T l e v e l s . * HDLC (mq5d1) + SE -- NS* This primate model shows hormone responsive l~p o p r o t e i n changes s i m i l a r t o humans. Sqreductase and aromatase ( e s t r o g e n ) a c t i v i t y do n o t appear t o be necessary f o r t h i s response. This model w i l l a l l o w f u r t h e r study of the mechanism of a c t i o n and b e n e f i t s o r s i d e effects of t h e r a p e u t i c i n t e r v e n t i o n w i t h antiandrogens.
AUKENULEUKUUYS'I'KUYHY MAY KESEiWLE
Grumbach, U n i v e r s i t y of C a l i f o r E i a , San Francisco, Dept. of P e d i a t r i c s , San Francisco Adrenoleukodystrophy (ALD) i s a well-described cause of f a m i l i a l primary a d r e n a l i n s u f f i c i e n c y i n which n e u r o l o g i c a l symptoms may be absent f o r many years. While t h e spectrum of a d r e n a l i n s u f f i c i e n c y i n ALD i s v a r i a b l e , primary impairment of g l u c o c o r t i c o i d s e c r e t i o n may resemble f a m i l i a l ACTH unresponsiveness, a d i f f e r e n t r a r e form of a d r e n a l i n s u f f i c i e n c y . To d i s t i n g u i s h ALU from o t h e r forms of f a m i l i a l a d r e n a l i n s u f f i c i e n c y , we c a r r i e d o u t t h e following s t u d i e s i n 3 male p a t i e n t s (age 11-16 y r ) : measurement of plasma s a t u r a t e d very-long-chain f a t t y a c i d s (C26 and C26lC22 r a t i o ) , a d r e n a l a n t i b o d i e s (AAb), plasma r e n i n a c t i v i t y (PRA), and computerized tomography (CT) o r magnetic resonance (MR) s t u d i e s of t h e CNS.
C26 was e l e v a t e d above c o n t r o l i n a l l t h r e e p a t i e n t s , 2.14 + 1.21 pglml, mean 2 S.D. (normal 0.33 + 0.18) a s was t h e C26/C22 r a t i o , 0.04 + 0.01 (normal 0.01 + 0.01), c o n s i s t e n t w i t h t h e d i a g n o s i s of ALD. AAb were u n d e t e c t a b l e i n a l l p a t i e n t s . PRA was normal i n one p a t i e n t and e l e v a t e d i n two. Neurological examinations were unremarkable i n a l l p a t i e n t s , without evidence of leukodystrophy on CT o r MR scans. This s t u d y i l l u s t r a t e s t h e need t o c o n s i d e r ALD i n t h e d i f f e r e n t i a l d i a g n o s i s of childhood f a m i l i a l primary a d r e n a l i n s u f f i c i e n c y i n t h e absence of n e u r o l o g i c a l symptoms. Precocious puberty was observed in a preterm (27 wks post-conceptional age -PCA) female. At 41 wks PCA, estradiol (E2) levels were elevated (282 pg/ml). By 13 months PCA, E2 decreased spontaneously (18 pg/ml) and pubertal changes regressed. However, pelvic ultrasonography revealed the development of ovarian cysts. In order to interpret these findings and determine their significance, we studied 6 normal preterm female infants (PCA 234 wks) during the first month of postnatal life. We measured: a) E2 -max > 3 0 , 0 0 0 pg/ml on day of birth (DOB), b) LH -max 1 9 6 mIu/ml on DOB, c) FSH -max 125.2 mIu/ml 3 wks after birth, d) 17-hydroxyprogesterone -max 4320 ng/dl on DOB, and el DHEA-S -max 429 ug/dl on DOB. As in full term infants, E2 was highest on the DOB and decreased to prepubertal values within 1 month. In contrast, gonadotropin levels were variable but remained elevated throughout this period. Conclusions: Although in most preterm females elevated gonadotropin levels persist for at least 1 month, the same is not true for E2. These data suggest that the HPG axis is activated in premature female infants prior to their would be term delivery. The index case differed in that elevated E2 levels persisted and ovarian cysts developed.
Furthermore, i t i s important t o recognize t h a t ALD may p r e s e n t w i t h i s o l a t e d g l u c o r t i c o i d d e f i c i e n c y and t h u s may mimic ACTH unresponsiveness, which has s e p a r a t e g e n e t i c , p r o g n o s t i c , and t h e r a p e u t i c c o n s i d e r a t i o n s .

ACTIVATION OF THE HYPOTHALAMIC-PITUITARY-GONADAL (HPG) AXIS IN PRETERM FEMALES. Lvnn
SUPPRESSION OF GROWTH HORMONE AND THYROID HORMONE ASSOCIATED WITH VALPROIC ACID THERAPY.
Carol A. Huseman, Richard D. Torkelson, U n i v e r s i t y o f -4 4 9 Nebraska, U n i v e r s z y of Nebraska Medical Center, Departments of P e d i a t r i c s and Neurology, Omaha, NE.
Valproic a c i d (VA) i s a commonly used anticonvuls a n t . One proposed mechanism of a c t i o n f o r V A i s enhancement of c e n t r a l GABAergic tone by i n h i b i t i o n of GABA transaminase. We r e p o r t suppression of somatic ~r o w t h , hGH. and t h v r o i d f u n c t i o n i n 5 e i F l s . a e e s 2-14 v e a r s ; r n a i n t a i n b "Normal v a l u e s (A) and (B) > 10 **Somatomedin-C = Abn i n Bold
All c h i l d r e n showed suppressed hGH v a l u e s t o L-Dopa(A) o r insulin(B) t e s t i n g during V A therapy.
hGH responses, Free T4 and SMC v a l u e s normalized with concomitant i n c r e a s e s i n growth vel o c i t y a f t e r V A was stopped. Summary: Chronic V A therapy can suppress hGH, T4, .SMC, and i n h i b i t growth. This e f f e c t may be due t o exhaustron of t h e s t i m u l a t o r y e f f e c t of GABA on t h e somatotrope o r t h y r o t r o p e d u r i n g chronic V A therapy. Growth must be c a r e f u l l y monitored i n a l l p a t i e n t s on V A theraov. A 450 of Pediatrics., Stanford University Medical Center, Stanford, CA.
THE DIFFERENTIAL EXPRESSION OF INSULIN-LIKE GROWTH
Buffalo Rat Liver 3A (BRL) and 18,54-SF cells are two rat tumor cell lines which have been maintained continuously in serum-free media. Both cell lines secrete rat IGF-II (>50ng/ml in three day conditioned media) and have no detectable rlGF-I peptide by RIA. The experimental design was to: 1) demonstrate that lack of rlGF-I production was due to absent transcription of rlGF-I mRNA, and 2) to compare BRL, 18,54-SF and rat liver IGF-II RNA sizes and abundance patterns on Northern blots. RNA was prepared by the guainidine thiocyanatelLiCl technique. Polyadenylated RNA (A+) was separated from nonpolyadenylated RNA (A-) by oligo-dT cellulose chromatography, sized on for~naldehvde-aqarose qels and transferred to nvlon membranes. IGF RNA sequences wers detected either by hybridization io in vrtro transcribed cRNA specitic to each strand, or to in v~tro hexamer primed DNA at a specific actlvlly > 109 cpmbg. Probes were to i) the carboxyl terminal E peptides and 3' nontranslated regions which are highly specif~c for each of the two IGF species and ii) the 5' reg:on of IGF-I thus allowinD detection of both IGF-I sol~cirw variants. Non-s~ecilic bindinq was reduced by final washing in 0 . 1~ S S C '~~ 6 k . IGF-I ~R N A ' C O U~~ not bg detected in BRL nor 18.54-SF cells but was easily detected in adult rat liver as 1800 and 660 base major species with -6 intermediate forms. IGF-II mRNA was detected by the 3' cDNA and 3' anti-sense cRNA probes; no species were found to hybridize with the 3' sense cRNA, indicating that all rnRNAs are in the usual 5' to 3' sense orientation. The BRL and 18,54-SF cells had multiple IGF-II forms (>lOkb, 7.0kb, 5.8kb, 4.4kb, 3.5kb, 3.0kb, 2.7kb . 2.5kb, 1.8kb and 1.lkb). The most abundant form in BRL cells was 5.8kb in length and polyadenylated. The predominant form in 18.54-SF cells was 4.4kb in length and this was the most abundant A+ form; additionally an A-form at 1 .lkb was observed. Adult rat liver had no detectable IGF-II RNA sequences. These data demonstrate that regulated expression occurs at the level of transcription. The presence of rlGF-II mRNA and peptide in the absence of rlGF-I mRNA and peptide, coupled with the ability to grow in serum free defined media support IGF-II as being a critical growth factor in these cell lines.
GLUCOCORTICOIDS REGULATE ADRENAL OPIATE PEPTIDES E.F. La Gamma, J.E. Adler,
